FTC Extends Warning Letters Over ‘Junk’ Patents To Ozempic And Other Drugs

… for Novo Nordisk’s blockbuster drug Ozempic and other drugs for diabetes, weight loss, asthma and chronic obstructive pulmonary disease (COPD).